Owkin

Owkin build AI agents for biology to accelerate drug discovery and de-risk clinical trials. The Owkin connector currently powers HistoPLUS, an agent that transforms H&E slides from the TCGA database into granular, queryable insights. Researchers can use it to quantify distinct cell types, analyze complex spatial tumor microenvironments, and validate hypotheses through cohort-level survival analysis. Use this connector to bridge the gap between raw biological data and actionable patient stratification, starting with histopathology.

First seen 2 Oct 2026. Evidence as of 2 Oct 2026.